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Abstract
Nerve injury-induced expression of the spinal calcium channel alpha-2-delta-1 subunit (Cavα2δ1)
has been shown to mediate behavioral hypersensitivity through a yet identified mechanism. We
examined if this neuroplasticity modulates behavioral hypersensitivity by regulating spinal
glutamatergic neurotransmission in injury-free transgenic mice overexpressing the Cavα2δ1
proteins in neuronal tissues. The transgenic mice exhibited hypersensitivity to mechanical
stimulation (allodynia) similar to the spinal nerve ligation injury model. Intrathecally delivered
antagonists for N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxyl-5-methylisoxazole-4-
propionic acid (AMPA)/kainate receptors, but not for the metabotropic glutamate receptors,
caused a dose-dependent allodynia reversal in the transgenic mice without changing the behavioral
sensitivity in wild-type mice. This suggests that elevated spinal Cavα2δ1 mediates allodynia through
a pathway involving activation of selective glutamate receptors. To determine if this is mediated by
enhanced spinal neuronal excitability or pre-synaptic glutamate release in deep-dorsal horn, we
examined wide-dynamic-range (WDR) neuron excitability with extracellular recording and
glutamate-mediated excitatory postsynaptic currents with whole-cell patch recording in deep-
dorsal horn of the Cavα2δ1 transgenic mice. Our data indicated that overexpression of Cavα2δ1 in
neuronal tissues led to increased frequency, but not amplitude, of miniature excitatory post
synaptic currents mediated mainly by AMPA/kainate receptors at physiological membrane
potentials, and also by NMDA receptors upon depolarization, without changing the excitability of
WDR neurons to high intensity stimulation. Together, these findings support a mechanism of
Cavα2δ1-mediated spinal sensitization in which elevated Cavα2δ1 causes increased pre-synaptic
glutamate release that leads to reduced excitation thresholds of post-synaptic dorsal horn neurons
to innocuous stimuli. This spinal sensitization mechanism may mediate at least partially the
neuropathic pain states derived from increased pre-synaptic Cavα2δ1 expression.
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Chronic pain derived from nerve injuries, or neuropathic
pain, is a common clinical problem affecting over 50 mil-
lion people in the United States [1]. Neuropathic pain
may manifest as spontaneous pain, pain resulting from
stimuli that are normally innocuous (allodynia), and
increased pain responses to suprathreshold stimuli
(hyperalgesia), all of which affect adversely the quality of
patients' daily-life. Unfortunately, neuropathic pain tends
to be long-term, and difficult to manage due to the poor
efficacies and severe side effects associated with current
conventional analgesic treatments. It appears that neuro-
pathic pain with various etiologies can lead to similar
behavioral endpoints that response differentially to phar-
macological agents, suggesting that different mechanisms
may underlie specific neuropathic pain states deriving
from different pathological conditions. Thus, the develop-
ment of target specific, safe and effective agents for neuro-
pathic pain management relies on new insights into
mechanisms of different neuropathic pain states.
Findings from previous studies have indicated that
peripheral nerve injury induces a dramatic upregulation
of the voltage-gated calcium channel (VGCC) α2δ1 subu-
nit (Cavα2δ1) in sensory neurons and spinal dorsal horn
[2-6], which correlates with neuropathic pain develop-
ment [2,3,7]. Knocking down of injury-induced Cavα2δ1
upregulation in dorsal spinal cord with intrathecal anti-
sense oligodeoxynucleotides results in allodynia reversal
in spinal nerve injured rats [7]. In addition, transgenic
mice overexpressing Cavα2δ1 in neuronal tissue display
tactile allodynia similar to nerve injury models that can be
blocked by intrathecal gabapentin [8], a drug that binds to
the Cavα2δ1 proteins with high affinity [9] and has anti-
neuropathic pain properties in patients and experimental
animal models [2,3,10-16]. Furthermore, blocking axonal
transport of injury-induced Cavα2δ1 from DRG neurons to
their pre-synaptic terminals in spinal dorsal horn dimin-
ishes tactile allodynia in nerve-injured animals [7].
Together, these findings suggest that elevated Cavα2δ1
likely contributes to behavioral hypersensitivity through a
pre-synaptic mechanism at the spinal cord level. This
hypothesis, however, has not been tested directly.
Since elevated Cavα2δ1 in the transgenic mice has been
shown to cause dorsal horn neuron hyperexcitability,
behavioral hypersensitivity [8]; enhanced glutamate neu-
rotransmission is an important mediator in neuropathic
pain processing [17,18]; and elevated Cavα2δ1 may modu-
late various calcium channels that are known to regulate
spinal pre-synaptic neurotransmission [19-25], we exam-
ined if elevated Cavα2δ1 mediated deep-dorsal horn neu-
ron excitability and behavioral hypersensitivity through
activation of glutamate receptors, and if so, whether it was
mediated by a pre-synaptic or post-synaptic mechanism.
We tested these hypotheses in the injury-free Cavα2δ1-
overexpressing transgenic mouse model showing dorsal
horn neuron hyperexcitability and behavioral hypersensi-
tivity without the influence from other nerve injury factors
[8].
Results
A similar tactile allodynia state is developed in spinal nerve 
injured mice and injury-free Cavα2δ1 transgenic mice
Our previous studies have indicated that unilateral spinal
nerve ligation (SNL) induces upregulation of the Cavα2δ1
subunit in DRG and spinal dorsal horn that plays a critical
role in tactile allodynia development [2,7]. However,
nerve injury may also induce altered expression of other
factors and activation of other pathways independent of
the Cavα2δ1 induction, which may also contribute to tac-
tile allodynia development. To determine if injury-
induced Cavα2δ1 alone is sufficient to induce tactile allo-
dynia, we examined the behavioral response of transgenic
(TG) mice overexpressing the Cavα2δ1 proteins in neuro-
nal tissues [8]. Similar to the SNL mice (Fig. 1 left), the
injury-free Cavα2δ1 TG mice also developed a similar allo-
dynic state compared with their wild-type (WT) litterma-
tes (Fig. 1, right). Since other factors in these two models,
Increased Cavα2δ1 expression in spinal cord and DRG corre-lates with tactile allodynia n spinal nerve ligate and injury-fre  Cavα2δ1 TG miceFigure 1
Increased Cavα2δ1 expression in spinal cord and DRG 
correlates with tactile allodynia in spinal nerve 
ligated and injury-free Cavα2δ1 TG mice. Unilateral L5 
spinal nerve ligation (SNL) surgeries were performed in mice, 
and paw withdrawal thresholds (PWT) to von Frey filament 
stimulation were measured two-weeks post injury in SNL 
mice or in injury-free, adult male Cavα2δ1 TG and WT mice 
as described in the Methods. Data presented are the means 
± SEM from n = 6 for the SNL group, and n = 12 each for the 
injury-free WT and TG groups. C – contralateral (non-
injury) side. Ip – ipsilateral (injury) side. * p < 0.05 compared 
to contralateral side or WT control using unpaired Students' 
t test.
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compensatory factors in the Cavα2δ1 TG mice, are not
likely the same, these data support that elevated Cavα2δ1
is highly likely a common factor mediating the abnormal
sensations seen in these two models. This is supported by
the findings that the tactile allodynia in both models can
be blocked by treatment with intrathecal gabapentin
[2,8,10], which binds to the Cavα2δ1 subunit [9].
A spinal glutamatergic pathway mediates behavioral 
hypersensitivity in the Cavα2δ1-transgenic mice
The pathway underlying Cavα2δ1-mediated behavioral
hypersensitivity is not known. Since activation of gluta-
mate receptors plays a role in central sensitization in pain
processing [18,26-29] and activation of selective gluta-
mate receptors is believed to play a critical role in SNL-
induced tactile allodynia [17,18], we tested the hypothesis
that glutamate receptor activation might underlie the
Cavα2δ1-mediated behavioral hypersensitivity in the TG
mice by examining the effects of intrathecal glutamate
receptor antagonists on allodynia reversal in the TG mice.
Intrathecal injection of memantine, a selective N-methyl-
D-aspartate (NMDA) receptor antagonist, caused a dose-
dependent allodynia reversal in the Cavα2δ1 TG mice (Fig.
2A). Its anti-allodynic effects at the highest dose tested (2
mg/kg) lasted for two-three hrs (Fig. 2B), and diminished
completely overnight (data not shown). Similar drug
treatment in the WT littermates led to a slight increase of
behavioral thresholds to the same type of mechanical
stimulation, which was not statistically significant com-
pared with the pretreatment level (Fig. 2). The allodynia
reversal by memantine was similar to that reported in the
SNL model [17].
Intrathecal injection of 6,7-dinitroquinoxaline-2,3-dione
(DNQX), a non-NMDA receptor antagonist for the α-
amino-3-hydroxyl-5-methylisoxazole-4-propionic acid
(AMPA)/kainate receptors, at a dose of 50 μg/kg provided
little allodynia reversal in the TG mice. However, intrath-
ecal DNQX at a higher dose (0.15 mg/kg) provided a
rapid onset and transient allodynia reversal in the TG
mice (Fig. 3), similar to that reported in the SNL model
[17]. Similar DNQX treatment in the WT littermates led to
a slight increase of behavioral thresholds to the same type
of mechanical stimulation, which was not statistically sig-
nificant compared with the pretreatment level (Fig. 3).
Intrathecal injection of 2-amino-3-phosphonopropionic
acid (AP3), a non-competitive metabotropic glutamate
receptor antagonist, at a maximum tolerable dose
reported (50 μg/kg) [17], did not significantly reverse tac-
tile allodynia in the TG mice (Fig. 4), which was in agree-
ment with findings from the SNL model [17].
Cavα2δ1-mediated spinal hyperexcitability through 
enhanced pre-synaptic glutamate release, but not likely 
through enhanced intrinsic excitability of dorsal horn 
neurons
We reported previously that elevated Cavα2δ1 in the TG
mice, without other injury induced factors, was sufficient
to cause WDR neuron hyperexcitability and behavioral
hypersensitivity [8]. Data from our previous studies have
indicated that intrathecal injection of gabapentin, a drug
that binds to Cavα2δ1 proteins and has anti-neuropathic
pain efficacy in the SNL model [2,3,10-12] and patients
[13-15], can reverse the behavioral hypersensitivity in the
Cavα2δ1 TG mice [8], supporting that Cavα2δ1-mediated
WDR neuron activation contributes at least partially to the
behavioral hypersensitivity. Since the wind-up response, a
phenomenon of progressively exaggerated WDR neuron
excitability to repetitive C-fiber stimulation, is similar
between the TG and WT littermates [8], the hyperexcita-
bility of the TG dorsal horn neurons is not likely mediated
by a facilitated state mediated by the wind-up mechanism.
To test if Cavα2δ1 overexpression affects post-synaptic dor-
sal horn neuron excitability to acute stimuli, we compared
C-fiber responses, post discharges, and non-potentiated
responses (input) of WDR neurons from TG and WT litter-
mates after brief transcutaneous electric stimulation with
the C-fiber intensity. As shown in Fig. 5, similar levels of
end point measures were observed between the TG and
WT neurons. Even though our data do not allow the com-
plete exclusion about possible influences from changes in
strength of C-fiber synaptic inputs onto TG neurons, the
occurrence of these changes, if any, would require oppo-
site compensations in the excitability of TG neurons to
maintain a level of excitability similar to that observed in
WT mice, which are not supported by reported findings
[8]. Thus, these findings suggest that the intrinsic excita-
bility of WDR neurons, at least that to acute C-fiber
inputs, is not changed in the Cavα2δ1 TG mice.
This is further supported by our findings that elevated
AMPA/kainate and NMDA receptor-mediated miniature
excitatory postsynaptic currents (mEPSCs) in TG deep-
dorsal horn neurons are at least partially mediated by
enhanced pre-synaptic glutamate release, but not by
changes in post-synaptic components, including
enhanced intrinsic excitability of post-synaptic deep dor-
sal horn neurons. As shown in Fig. 6A and 6B, at a holding
potential of -70 mV, the frequency of AMPA/kainate
receptor mediated mEPSCs was significantly increased
from 0.22 ± 0.06 Hz for WT neurons (n = 7) to 0.79 ± 0.08
Hz for the TG neurons (n = 9). Application of AMPA/kai-
nate receptor antagonist CNQX (10 μM) could reduce
mEPSCs by 91.3 ± 5.3% and 93.9 ± 3.3% in WT and TG
neurons (n = 5 in each group, data not shown), respec-
tively. In the presence of CNQX (10 μM), the frequency ofPage 3 of 13
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potential of +50 mV, was also increased in the TG neurons
(WT: 0.03 ± 0.02 Hz, n = 5; TG: 0.12 ± 0.01, n = 3). How-
ever, the amplitudes of AMPA/kainate and NMDA recep-
tor mediated mEPSCs were about the same between the
WT and TG neurons. In addition, the kinetics of the
AMPA/kainate and NMDA receptor mediated mEPSCs
showed no obvious difference between the WT and TG
neurons (Fig. 6C and 6D). The rising time of AMPA/kain-
ate receptor mediated mEPSCs was 1.19 ± 0.10 ms (n = 7)
and 1.26 ± 0.09 ms (n = 9) in WT and TG neurons, respec-
tively, and the decay time constant was 5.05 ± 0.43 ms (n
= 7) and 5.12 ± 0.39 ms (n = 9) in WT and TG neurons,
respectively. The rising time of NMDA receptor mediated
mEPSCs was 1.82 ± 0.11 ms (n = 3) in WT and 1.70 ± 0.05
ms (n = 3) in TG neurons, and the decay time constant
was 15.13 ± 0.34 ms (n = 3) in WT and 14.70 ± 1.29 ms
(n = 3) in TG neurons.
Intrathecal NMDA receptor antagonists reverse tactile allodynia in the TG miceFigure 2 (see previous page)
Intrathecal NMDA receptor antagonists reverse tactile allodynia in the TG mice. Memantine, an NMDA receptor 
antagonist, was injected intrathecally between L5/6 lumbar regions into adult TG and WT mice, and behavioral sensitivities to 
mechanical stimulation before or after drug treatments were assessed blindly as paw withdrawal thresholds (PWT) to von Frey 
filament stimulation in the hindpaw. A. Dose-dependent effects of intrathecal memantine for PWT in the TG and WT mice 
measured 120 min post i.t. injection. Data shown represent the means ± SEM from n = 7 for each group. ## p < 0.01, ### p < 
0.001 compared with WT mice, *** p < 0.001 compared with the pretreatment level using two-way ANOVA followed by Bon-
ferroni post-tests. B. Time-dependent effects of intrathecal memantine (2.0 mg/kg) on allodynia reversal in TG mice compared 
with saline treatment and similar treatments in WT mice. Data shown represent the means ± SEM from n = 7 for each group. 
* p < 0.05, ** p < 0.01 compared with the pretreatment level, $ p < 0.05, $$$ p < 0.001 compared with saline treatment in TG 
mice using two-way ANOVA followed by Bonferroni post-tests.
Intrathecal AMPA/kainate receptor antagonists reverse tactile allodynia in the TG miceFigure 3
Intrathecal AMPA/kainate receptor antagonists reverse tactile allodynia in the TG mice. Different doses of 
DNQX, an antagonist of AMPA/kainate receptors, were injected intrathecally between L5/6 lumbar regions into adult TG and 
WT mice, and behavioral sensitivities to mechanical stimulation before or after drug treatments were assessed blindly as paw 
withdrawal thresholds (PWT) to von Frey filament stimulation in the hindpaw. Data shown are the dose- and time-dependent 
effects of intrathecal DNQX on allodynia reversal in TG mice compared with saline treatment or similar treatment in the WT 
mice. For the purpose of clarity, effects of the lower dose of DNQX (50 μg/kg) on PWT of WT mice, which were similar to 
that in saline treated WT mice, were not shown. Means ± SEM from n = 7 for each group. ** p < 0.01, *** p < 0.001 compared 
with the pretreatment level, $ p < 0.05, $$$ p < 0.001 compared with saline treatment in TG mice using two-way ANOVA fol-
lowed by Bonferroni post-tests.
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While previous evidences have indicated a clear correla-
tion between nerve injury-induced Cavα2δ1 upregulation
and neuropathic pain states [3,4,7], pathways underlying
Cavα2δ1-mediated behavioral hypersensitivity have not
been identified. Since cellular changes in spinal cord and
DRG after a prolonged peripheral nerve injury include
altered expression of large numbers of genes [5,6,30],
multiple factors induced by nerve injury may contribute
to neuropathic hypersensitivity. In an attempt to study if
upregulated Cavα2δ1 is sufficient to mediate behavioral
hypersensitivity, and if so, what is the underlying mecha-
nism, we have generated TG mice overexpressing Cavα2δ1
in neuronal tissues and compared their behavioral sensi-
tivity to mechanical stimulation with the SNL model. Our
data indicated that the TG mice have tactile allodynia sim-
ilar to that observed in the SNL model. Since similar
behavioral hypersensitivity and increased Cavα2δ1 expres-
sion occur in both models, and other factors such as com-
pensatory changes in the TG mice and other injury-
induced factors in the SNL model are not likely the same,
our data, while do not allow the complete exclusion of
other factors, strongly support that increased Cavα2δ1 pro-
teins are sufficient in mediating tactile allodynia observed
in these models.
The pharmacology profiles in allodynia reversal by the
spinally delivered, selective glutamate receptor antago-
nists are consistent with the pharmacology profiles of
allodynia reversal by these agents in the SNL model as
reported by others [17]. These data suggest that increased
Cavα2δ1 mediates allodynia through a pathway related to
a selective activation of AMPA/kainate and NMDA recep-
tors. In contrast, metabotropic glutamate receptor antago-
nist, AP3, was without effect in allodynia reversal. This is
consistent with the notion that metabotropic glutamate
receptors are mainly involved in acute and persistent pain
states associated with input from afferent C-fibers, but less
so on tactile allodynia likely mediated by input from Aβ
fibers [31].
Since the TG mice have elevated Cavα2δ1 in different neu-
ronal tissues ranging from DRG in the peripheral to spinal
cord and supraspinal cord locations in the central nervous
system [7], it is possible that increased Cavα2δ1 expression
in peripheral as well as central locations in the TG mice
Intrathecal antagonism of metabotropic glutamate receptors does not cause allodynia reversal in the TG miceFigure 4
Intrathecal antagonism of metabotropic glutamate receptors does not cause allodynia reversal in the TG 
mice. AP3, a mGluR antagonist, was injected intrathecally between L5/6 lumbar regions into adult TG and WT mice, and 
behavioral sensitivities to mechanical stimulation before or after drug treatments were assessed blindly as paw withdrawal 
thresholds (PWT) to von Frey filament stimulation in the hindpaw. Data shown are time-dependent effects of intrathecal AP3, 
at the maximum tolerable dose (50 μg/kg), on PWT of TG and WT mice. Means ± SEM from n = 7 for each group.
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glutamate receptor-dependent mechanism. Therefore, the
enhanced dorsal horn neuronal excitability could derive
from altered pre-synaptic neurotransmission, intrinsic
post-synaptic neuron excitability or descending modula-
tion from supra-spinal locations in the TG mice. While
our data do not allow the exclusion of potential contribu-
tions to tactile allodynia by activated AMPA/kainate and
NMDA receptors at supra-spinal locations in the TG mice,
Chaplan et al. [17] reported that only spinal, but not i.c.v.,
injection of NMDA receptor antagonists reversed injury-
induced allodynia in the SNL model. This suggests that
activation of a spinal glutamatergic pathway is critical in
the development of neuropathic pain states post periph-
eral nerve injury.
Data from this study further demonstrate that, in contrast
to the enhanced excitability of TG WDR neurons to natu-
ral stimuli reported previously [8], acutely evoked excita-
bility of WDR neurons to C-fiber-strength electric
stimulation is not altered in the TG mice. While mecha-
nisms underlying this discrepancy are not clear, the sim-
plest explanation is that detected WDR neuron excitability
to natural stimuli derives from neuronal activation by
inputs from multiple sensory fibers including A-fibers,
and elevated Cavα2δ1 expression results in a higher excita-
bility of the WDR neuron to A-fiber-, but not C-fiber-,
strength stimulation (see discussion below). Thus, it is
likely that increased Cavα2δ1 expression mediates tactile
allodynia through a Cavα2δ1-dependent pathway by
enhancing synaptic strength of A-fibers. Indeed, this
hypothesis is consistent with reported findings that: (a)
The basal level of Cavα2δ1 expression is relatively high in
small DRG neurons, low in large DRG neurons [6,8], and
there is a dramatic increase in Cavα2δ1 expression in large
DRG neurons after SNL injury [6] or in the Cavα2δ1 TG
mice [8]; (b) increased Cavα2δ1 expression correlates with
development of allodynia mainly mediated by large Aβ
fibers, but not formalin- and carrageenan-induced acute
pain states mainly mediated by nociceptive C-fiber inputs
in the TG mice [8], and formalin- or carrageenan-induced
pain models do not have increased Cavα2δ1 expression in
DRG and spinal cord (data not shown); (c) increased
Cavα2δ1 expression in the TG mice does not alter the
receptive field sizes of WDR neurons, nor the excitability
of these neurons to repetitive C-fiber stimulation (wind-
up) [8]; (d) In the model of sciatic nerve chronic constric-
tion injury with increased Cavα2δ1 expression [3], a sub-
population of dorsal horn neurons exhibits abnormal
afterdischarges to mechanical and thermal stimuli, but the
number of dorsal horn neurons showing wind-up phe-
nomenon to repetitive C-fiber stimulation remains
unchanged [32].
The increase in frequency of AMPA/kainate and NMDA
receptor mediated mEPSCs in deep dorsal horn neurons
from the TG mice suggests that elevated spinal Cavα2δ1
proteins lead to an increased rate of quanta release of exci-
tatory neurotransmitter glutamate from pre-synaptic ter-
minals at the resting state, which in turn, enhances
excitability of post-synaptic dorsal horn neurons through
mainly AMPA/kainate receptor activation. Since the deep
dorsal horn neurons for in vitro and vivo recordings were
selected from a similar dorsal horn lamina, and very few
non-WDR neurons (which were excluded) were detected
in this lamina during neuron sampling in vivo, it is highly
likely that a similar population of WDR neurons was
examined in our in vivo and in vitro recording. Our data
indicate that elevated Cavα2δ1 proteins do not change the
amplitudes of AMPA/kainate and NMDA receptor-medi-
ated mEPSCs. This suggests that neither the quantum size
of glutamate release nor the intrinsic excitability of post-
synaptic dorsal horn neurons to glutamate receptor activa-
tion is changed by increased Cavα2δ1 expression. Direct
measurements of glutamate release in deep dorsal horn
and membrane excitability of WDR neurons from TG
mice would further help to clarify these issues.
It remains elusive that AMPA/kainate receptor antagonists
only normalize behavioral hypersensitivity in the TG mice
Similar excitability to high intensity electrical stimulation between WT and TG wide-dy amic-range neuronsFigur  5
Similar excitability to high intensity electrical stimu-
lation between WT and TG wide-dynamic-range 
neurons. Extracellular recordings were performed blindly to 
record dorsal horn single WDR neuron activity in response 
to C-fiber strength electrical stimulation applied to the 
receptive fields over the hindpaw of the WT and TG mice. 
Numbers of spikes from each neuron were pooled and the 
data are presented as the means ± SEM from n = 10 in each 
group. C – C-fiber responses. PD – post discharge.Page 7 of 13
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significantly. It is likely that binding of glutamate to
AMPA receptors at a resting state causes a conformational
change of the receptors that is linked to channel opening
followed by desensitization of the receptors, a mechanism
controlling glutamate-induced neuron activation under
normal physiological conditions [33]. It is possible that
DNQX has lower binding affinity to AMPA receptors at
the conformation under physiological conditions, thus, is
less effective in blocking AMPA receptors. In the trans-
genic mice or under a pathological condition in which
pre-synaptic glutamate release is enhanced, the AMPA
receptor channels could be in a different conformational
state due to partial membrane depolarization and channel
opening [33], a primed state as suggested in Fig. 7B.
DNQX could have a higher affinity to this state, thus, be
more effective in blocking AMPA receptors in the TG mice
or pathological conditions. Alternatively, glutamate acti-
vation of kainate receptors at the pre-synaptic sensory
neuron terminals can reduce glutamate release [34], and
that at spinal interneurons can induce inhibitory trans-
mitter release [35], which together help to terminate tran-
sient activation of post-synaptic dorsal horn neurons
under normal physiological conditions. This heterosyn-
aptic regulation is transient due to kainate receptor desen-
sitization [35]. It is possible that this heterosynaptic
regulation is less sensitive to DNQX. However, in the TG
mice or under a pathological condition in which pre-syn-
aptic glutamate release is enhanced, prolonged activation
of kainate receptors at inhibitory interneurons can
enhance GABA release that may activate pre-synaptic
GABAB autoreceptors, which in turn, reduces potential-
Increased frequency, but not amplitude, of AMPA/kainate- and NMDA-receptor mediated mEPSCs in deep-dorsal horn neu-rons of the TG miceFigure 6
Increased frequency, but not amplitude, of AMPA/kainate- and NMDA-receptor mediated mEPSCs in deep-
dorsal horn neurons of the TG mice. Spinal cord slices were prepared from the WT and TG mice, and spontaneous mEP-
SCs were recorded blindly from deep-dorsal horn neurons. A. Representative traces mediated by AMPA/kainate and NMDA 
receptors, respectively. B. Summarized mEPSC frequency (left) and amplitude (right) from WT and TG neurons mediated by 
AMPA/kainate and NMDA receptors, respectively. C. Representative traces of AMPA/kainite receptor mediated mEPSCs 
recorded from WT and TG neurons. D. Summarized mEPSC rising time (left) and decay time constant (right) from WT and 
TG neurons mediated by AMPA/kainate and NMDA receptors, respectively. Data presented are the means ± SEM from the 
number of independent neurons indicated in the text. Statistic significance is indicated by p < 0.01 using unpaired Students' t 
test. n.s. – not significant
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Proposed mechanism of Cavα2δ1-mediated spinal hypersensitivityFigure 7
Proposed mechanism of Cavα2δ1-mediated spinal hypersensitivity. A model of enhanced spinal glutamate release illus-
trates the possible mechanism of Cavα2δ1-mediated spinal hypersensitivity. A. Under normal conditions, the Cavα2δ1 expres-
sion level and quantum release of excitatory neurotransmitter glutamate from pre-synaptic A-fiber terminals is low so that 
post-synaptic deep dorsal horn neurons maintain a normal excitation threshold. As a consequence, glutamate release in 
response to stimuli results in a physiological activation of deep dorsal horn neurons mainly by activating AMPA/kainate recep-
tors. The Cavα2δ1 expression level at C-fiber terminals is relatively high (causing a ceiling effect for C-fiber activation), but 
there is little C-fiber input onto deep dorsal horn neurons at a resting state. B. Under a pathological condition with an elevated 
Cavα2δ1-level at the A-fiber pre-synaptic terminals, such as post peripheral nerve injuries, the quantum release of glutamate 
from these terminals at a resting membrane potential is dramatically enhanced. This glutamate "leaking" causes a partial depo-
larization of post-synaptic deep dorsal horn neurons by activating AMPA/kainate receptors. As a consequence, these primed 
deep dorsal horn neurons have lowered excitation thresholds to subsequently evoked glutamate release, and also hyperexcita-
bility due to lowered thresholds to NMDA receptor activation. Neither the partial depolarization of deep dorsal horn neurons 
nor the increased Cavα2δ1 expression in C-fiber terminals has any detectable effect to high intensity C-fiber stimulations. C. 
Proposed potential mechanisms mediating the Cavα2δ1-enhancement of spinal glutamate release.
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hibition [35]. It is possible that DNQX is more effective in
blocking this prolonged activation of kainate receptors.
Finally, it is possible that the WT mice are relatively insen-
sitive to (Aβ-mediated) mechanical stimulation, possibly
due to the low level Cavα2δ1 expression in large neurons
as discussed previously, so that it is difficult to detect any
change in mechanical sensitivity. These possibilities may
be not mutually exclusive.
Nevertheless, findings from this study allow us to propose
the following mechanism of Cavα2δ1-mediated tactile
allodynia (Fig. 7): At the resting state under normal syn-
aptic functions, the expression levels of Cavα2δ1 in large
DRG neurons and A-fiber terminals are relatively low, so
as the rate of quanta glutamate release from A-fiber termi-
nals that maintains a normal neuronal excitation thresh-
old to innocuous stimulation. The Cavα2δ1 expression
levels in small DRG neurons and C-fiber terminals are rel-
atively high, but may have little effect on glutamate
release from C-fiber terminals at a resting state due to the
lack of C-fiber inputs. This high level of basal Cavα2δ1
expression in small DRG neurons may set up a ceiling
effect for the influence of Cavα2δ1 on WDR neuron excita-
bility to C-fiber or windup stimulations (discussed
below).
Mild pre-synaptic membrane depolarization in response
to an action potential leads to the opening of VGCC, trig-
gering calcium influx and a quantum release of excitatory
neurotransmitter glutamate. Binding of glutamate to post-
synaptic AMPA receptors at a resting state causes a confor-
mational change of the receptors that is linked to channel
opening, which is terminated by desensitization of the
receptors [33]. In addition, glutamate activation of kain-
ate receptors at the pre-synaptic sensory neuron terminals
can reduce glutamate release [34], and that at spinal
interneurons can induce inhibitory transmitter release
[35]. This heterosynaptic regulation, which is transient
due to kainate receptor desensitization, also plays a role in
terminating transient activation of post-synaptic dorsal
horn neurons under normal physiological conditions
[35]. Under normal physiological conditions, released
glutamate is insufficient in activating post-synaptic
NMDA receptors (Fig. 7A).
After peripheral nerve injuries, injury-induced Cavα2δ1
upregulation in DRG neurons, more so in large DRG neu-
rons, leads to increased axonal transport of Cavα2δ1 pro-
teins to central pre-synaptic terminals, which in turn
causes an increased rate of basal release of glutamate
through a yet identified mechanism. This "glutamate leak-
ing" causes partial sensitization of deep dorsal horn neu-
rons by activating mainly AMPA/kainate receptors at the
resting state. These "sensitized" dorsal horn neurons
therefore have lowered excitation thresholds to a subse-
quent release of glutamate in response to innocuous or
mild nociceptive stimuli that could evoke further confor-
mational change of the AMPA/kainate receptors and pro-
longed channel opening, leading to spinal
hyperexcitability. In addition, signals of mild noxious
stimulation could be further amplified in these sensitized
dorsal horn neurons due to their low thresholds to NMDA
receptor activation, leading to exaggerated painful sensa-
tions (Fig. 7B). These hyperexcitability states are sensitive
to antagonists of AMPA/kainate and NMDA receptors.
However, neither the partial neuron sensitization by
glutamate leaking from A-fiber terminals nor the
increased Cavα2δ1 expression in C-fiber terminals has any
detectable effect on WDR neuron excitability to high
intensity C-fiber stimulations (the ceiling effect discussed
above).
The detail mechanisms regarding how elevated
Cavα2δ1mediates enhanced pre-synaptic glutamate release
remain elusive (Fig. 7C). Based on in vitro data indicating
that Cavα2δ1 expression is required for normal membrane
expression of functional VGCC [36-40], which is critical
in mediating pre-synaptic neurotransmission, it is possi-
ble that elevated Cavα2δ1 leads to an enhanced VGCC
expression at the pre-synaptic terminals. However, there is
no direct evidence so far to support this hypothesis. Alter-
natively, recent findings in drosophila point to the direc-
tion that Cavα2δ plays a critical role in formation of pre-
synaptic structures and active zones related to pre-synaptic
neurotransmission [41]. Indeed, it has been proposed
that the ability of descending excitatory 5HT3 mediated
projections to induce a state-dependency in the actions of
gabapentin may also occur with the monoamine receptor
interacting with pre-synaptic mechanisms at the spinal
level [16]. Thus, it is possible that increased Cavα2δ1
causes enhanced synaptic strength and/or synapse num-
bers by promoting formation of more active zones
through a yet identified mechanism. These two possibili-
ties may not be mutually exclusive, and deserve further
investigation.
Conclusion
In conclusion, findings from this study support that ele-
vated Cavα2δ1 causes spinal hypersensitivity and tactile
allodynia through at least partially enhanced pre-synaptic
glutamate release, which may lead to sensitization of post-
synaptic dorsal horn neurons by lowering their thresholds
to innocuous stimuli. This spinal sensitization may con-
tribute to the neuropathic pain states derived from
increased pre-synaptic Cavα2δ1 expression.Page 10 of 13
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Animals
Transgenic mice over-expressing the Cavα2δ1 gene were
generated with a transgenic vector containing the mouse
brain Cavα2δ1 cDNA (Genbank accession number
U73484) down-stream of a 6.5 kb murine thy-1.2 gene
extending from the promoter region to the intron after
exon 4 without exon 3 and its flanking introns as
described previously [42]. Thy-1 is a member of the
immunoglobulin superfamily that is expressed in both
neuronal and non-neuronal tissues [43], and deletion of
exon 3 and its flanking introns has been shown to elimi-
nate expression in non-neuronal cells [44]. Only adult
male TG mice and their WT littermates were used for the
experiments. All the mice were fertile, appeared normal
with respect to grooming, social interactions and feeding,
and showed no signs of abnormality or any obvious
motor defects, tremor, seizure, or ataxia [8].
All animal care and experimental procedures were per-
formed based on protocols approved by the Institutional
Animal Care Committees of the University of California,
Irvine, University College London and Indiana University.
Neuropathic lesions
The surgical procedure of SNL was performed as described
[45]. Briefly, under isoflurane anesthesia, the left L5 spi-
nal nerve of mice were exposed and ligated with a silk
suture distal to DRG and proximal to their conjunction to
form the sciatic nerve. Sham operations were performed
in the same way except that spinal nerves were not ligated.
Behavioral assays
Behavioral response to mechanical stimulation was tested
blindly as described before and post drug treatments [8].
Briefly, mice were allowed to acclimatize for 1 hr in a clear
plastic cage with a wire mesh bottom. The 50% paw with-
drawal thresholds (PWT) to calibrated von Frey filament
(Stoelting, Wood Dale, IL) stimulation were determined
using a modified up-down method of Dixon [46]. A series
of filaments, starting with one that has a buckling weight
of 0.41 g, were applied in consecutive sequence to the
plantar surface of the left hindpaw with a pressure causing
the filament to buckle. Paw lifting within 5 s was consid-
ered a positive response and led to the use of the next
weaker filament. Absence of a paw lifting after 5 s led to
the use of the next filament with increasing weight. The
50% paw withdrawal threshold was calculated as
described before [2] from the resulting scores of six meas-
urements starting from the one prior to the first positive
response; or until four consecutive positive (assigned a
score of 0.01 g) or five consecutive negative (assigned a
score of 3 g) responses had occurred. Paw withdrawal
thresholds from each hindpaw of a SNL mouse were
recorded separately, or averaged paw withdrawal thresh-
olds from both hindpaws of the WT and injury-free
Cavα2δ1 TG mice were used for comparing sensitivities
between injury and non-injury side in SNL mice or
between injury-free WT and TG mice, respectively, with or
without drug treatment.
Drug administration
Drug working solutions were prepared in sterile saline
before intrathecal injections between lumbar regions 5–6
(5 μL/mouse) [47]. In some cases that multiple drugs were
used in the same group of animals, a three-day drug-free
period was introduced between each drug to ensure that
the previous drug was completely out, even though all the
drug effects in this study were terminated within 24 hr
post injection.
Electrophysiological recordings in dorsal horn neurons in 
vivo
Recordings were performed by examiners blinded to the
mouse genotype. Animals were placed in a stereotaxic
frame under anesthesia and the L3–L6 spinal segments
were exposed with a laminectomy. Extracellular record-
ings were made from individual wide dynamic range neu-
rons using parylene coated tungsten electrodes (A-M
Systems, USA). Neurons were visualized, isolated, and
discriminated based on their spike amplitudes and wave-
forms. All neurons used for recording had receptive fields
over the hindpaw. Depth of the neuron was measured
from the surface of the spinal cord. Spontaneous activity
was quantified over a period of at least 100 s in the
absence of any evoked stimulus on isolation of a neuron.
Electrical stimulation was given via two needles inserted
into the receptive field and the evoked activity was charac-
terized and quantified as follows. A train of 16 stimuli was
given (2 ms pulse duration, 0.5 Hz at three-times the C-
fiber threshold), and the evoked neuronal responses were
quantified using online analysis (Spike 2 software, CED
Cambridge UK). The evoked neuronal responses were
superimposed as a post-stimulus histogram and responses
identified – based on fiber conduction velocity and the
resulting latency – as C-fiber-evoked (50–250 msec)
action potentials. Neuronal responses occurring after the
C-fiber latency band of the neuron (250–800 ms) were
classed as post discharge. The 'input' (non-potentiated
response) was determined as: Input = [action potentials
(50–800 ms) evoked by first pulse at 3 times C-fiber
threshold] × total number of pulses.
Electrophysiological recordings in dorsal horn of spinal 
cord slices
Recordings were performed by examiners blinded to the
mouse genotype. The animals were anesthetized with ket-
amine-HCl (1 mg/kg, i.p.) and the spinal cord was
extracted by hydraulic extrusion. Transverse slices (330Page 11 of 13
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vibratome (VT1000S; Leica, Nussloch, Germany) in an
ice-cold (4°C) sucrose solution containing (in mM): 230
sucrose, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 0.5 CaCl2,
10 MgSO4, 10 glucose, pH 7.4, 290–305 mOsm/L, equil-
ibrated with 95% O2 and 5% CO2. The slices were main-
tained in an artificial cerebrospinal fluid (ACSF)
containing (in mM): 130 NaCl, 3 KCl, 2 CaCl2, 2 MgCl2,
1.25 NaH2PO4, 26 NaHCO3, and 10 glucose, pH 7.4,
295–305 mOsm/L. The ACSF was continuously equili-
brated with 95% O2 and 5% CO2, and slices were incu-
bated for > 1 h before recording. Recording electrodes
were prepared from borosilicate glass (World Precision
Instruments, Sarasota, FL) using a horizontal electrode
puller (P-97; Sutter Instruments, Novato, CA). Electrodes
had resistances of 2–4 MΩ when filled with an intracellu-
lar solution containing (in mM): 92 CsMeSO4, 43 CsCl, 1
MgCl2, 2 EGTA, 5 TEA, 10 HEPES and 2 Mg-ATP, pH 7.4,
295–300 mOsm/L. Oxygenated ACSF was used as bath
solution, and the flow rate was adjusted to 2–3 mL/min.
Depth of the neuron was measured from the surface of the
spinal cord and neurons in the deep dorsal horn were vis-
ualized with an infrared-differential interference contrast
(DIC) microscope (BX50WI; Olympus Optical, Tokyo,
Japan) and a CCD camera. All recordings were performed
at 25 ± 1°C with an Axopatch 200B amplifier (Molecular
Devices, Foster City, CA). During whole-cell recordings,
series resistance (8–15 MΩ) was monitored periodically,
and cells with > 15% changes were excluded from the
analysis. Signals were filtered at 1 kHz and digitized at a
sampling rate of 5 kHz using a data-acquisition program
(Axograph 4.6; Molecular Devices).
To record mEPSCs, tetrodotoxin (1 μM) and bicuculline
(30 μM) were continuously applied in the bath solution.
At a holding potential of -70 mV, the recorded mEPSCs
were mainly mediated by AMPA/kainate receptors
because application of AMPA/kainate receptor antagonist
CNQX (10 μM) could reduce mEPSCs by 91.3 ± 5.3% and
93.9 ± 3.3% in WT and TG neurons (n = 5 in each group),
respectively. In the presence of CNQX (10 μM), NMDA
receptor-mediated mEPSCs were recorded at a holding
potential of +50 mV.
Statistical Analyses
Indicated significant changes were defined by the two-
tailed p values as determined with unpaired Student's t
test, or two-way ANOVA followed by Bonferroni post-
tests.
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